The future of prognostic factors in outcome prediction for patients with cancer.
about
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference.Preoperative staging of rectal carcinoma.Methodological challenges in the evaluation of prognostic factors in breast cancer.Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review.Statistical methods in cancer research.Novel diagnostic biomarkers for prostate cancer.Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.Are laboratory investigations recommended in current medical practice guidelines supported by available evidence?Molecular detection approaches for smoking associated tumors.Machine learning applications in cancer prognosis and predictionCell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer.Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissuePrediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancerPrognostic factors and survival in a heterogeneous sample of cancer patientsPreoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomasREporting recommendations for tumour MARKer prognostic studies (REMARK)Applications of machine learning in cancer prediction and prognosisMetastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.Current prognostic factors for prostate carcinoma.Staging of cancer revisited.Sample size: how many patients are necessary?Immunohistochemistry, a valuable tool in detection of cervical lymph node micrometastases in head and neck squamous cell carcinoma: a prospective study.Anemia as an independent prognostic factor for survival in patients with cancer.A new pN staging system based on both the number and anatomic location of metastatic lymph nodes in gastric cancer.Bioactive actions of pomegranate fruit extracts on leukemia cell lines in vitro hold promise for new therapeutic agents for leukemia.Identification of clinically useful cancer prognostic factors: what are we missing?Squamous Cell Carcinoma of the Thyroid: An Aggressive Tumor Associated with Tall Cell Variant of Papillary Thyroid CarcinomaEffect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion
P2860
Q30358472-83C7C12C-63B0-46E0-92E2-493821925D8CQ33535189-76B14C69-303E-4B72-9A2D-93B9D003AF89Q33538459-BA1482B7-243E-4DE1-ADC5-B927F4F5CE29Q34004381-BF1356E0-E667-4607-BAC1-2A22899882A2Q34199563-9DDBF34B-B528-458E-A894-2DAF28F44CB7Q34231678-CD8B0B9E-D89C-44CC-B341-582CFC8DE8D8Q34522010-0CD6ED29-3B59-44AB-938D-2ECCB45EECB8Q34631706-58B470E7-26B9-477A-8EC5-41259AF25F22Q34634302-4FC33EBD-0433-43C0-8E30-F027F4BD53B5Q34963422-90694A58-56AA-4B76-B984-E30FE887D2B0Q35143671-CB3232E7-8620-4BBD-A55C-1283C7BD6265Q35588677-5B089590-03C3-45A2-A4D3-BF711AF76814Q36116240-AF4BB7CD-1194-4881-900F-6C0F2E2F5E2FQ36135184-ECD3BF0A-BE9B-4E97-B412-B985D43882D4Q36135291-DFC73A5C-5CDB-4801-B72E-AEDE20ADC317Q36136162-07A5255F-F017-4001-83D7-5E3039E770FCQ36421697-3B0C855A-E603-41FA-A607-7003F1E47884Q36615178-3E36F2D1-177C-4649-8853-6FC74B3F8499Q37175004-37B563F9-00AC-4EED-90E8-EA72F616D89FQ37492974-87196D69-01DC-437A-821F-834E50C243ACQ41010822-731B1922-0E71-436F-B82F-F9541289F566Q42383871-FED6C8F9-2382-4332-B251-AEA85FAC28AFQ42591001-0ED82FBC-EA69-4BB0-946D-B2035EB06E5FQ43081190-22A6F75D-6B9E-41A4-86DD-EAC28E1DABA1Q43680780-B000DFD6-B09D-430F-9BA7-A25DDFD31E90Q45732710-7D74A7F7-92E9-4117-8889-F75C04305915Q50265581-E6D358BA-76E7-47BD-A2FC-06AAF81F5AA5Q52979961-C9A2B776-D0EC-4695-AAD0-89B1207412E2Q58053897-059ED9B8-B4A4-475F-B71C-54B8B148D115Q58790279-F3155601-C30B-4511-B2F6-2F0302C710AE
P2860
The future of prognostic factors in outcome prediction for patients with cancer.
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The future of prognostic factors in outcome prediction for patients with cancer.
@ast
The future of prognostic factors in outcome prediction for patients with cancer.
@en
type
label
The future of prognostic factors in outcome prediction for patients with cancer.
@ast
The future of prognostic factors in outcome prediction for patients with cancer.
@en
prefLabel
The future of prognostic factors in outcome prediction for patients with cancer.
@ast
The future of prognostic factors in outcome prediction for patients with cancer.
@en
P2093
P2860
P1433
P1476
The future of prognostic factors in outcome prediction for patients with cancer.
@en
P2093
Fenoglio-Preiser CM
Fielding LP
Freedman LS
P2860
P304
P356
10.1002/1097-0142(19921101)70:9<2367::AID-CNCR2820700927>3.0.CO;2-B
P407
P577
1992-11-01T00:00:00Z